-
Astellas to acquire Ganymed
TOKYO and MAINZ, Germany — In a move that would expand its oncology pipeline, Astellas Pharma announced Friday its agreement to acquire Ganymed Pharmaceuticals for €422 million, or about $461 million.Under the agreement, Astellas would acquire 100% of the equity in Ganymed and Ganymed shareholders will be able to receive up to €860 million in further contingent payments tied to the progress of Ganymed’s most advanced clinical program, IMAB362. Ganymed would become a wholly owned subsidiary of Astellas.
-
'Spread Hope, Not the Flu' campaign raises $1.8 million for Rite Aid's KidCents
CAMP HILL, Pa. - The Rite Aid Foundation announced this week that it is donating more than $1.8 million to KidCents charities on behalf of Rite Aid customers who received a flu shot this year. Each of the more than 360 KidCents charities, located in communities served by Rite Aid, will receive a $5,000 grant to support programs that improve the health and well-being of children in their communities.
